A Study of Donafenib Monotherapy in Advanced Oesophageal Cancer
Clinical trial NCT02489201 · TERMINATED
Trial details
- NCT number
- NCT02489201
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-21
- Primary completion
- 2020-10-29
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.